Orphapacket:
  AverageAgeOfOnsets:
  - AverageAgeOfOnset:
      value: Adolescent
  - AverageAgeOfOnset:
      value: Adult
  - AverageAgeOfOnset:
      value: Childhood
  - AverageAgeOfOnset:
      value: Elderly
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
    value: Disease
  ExternalReferences:
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHAcode is broader than the targeted code used
        to represent it)
      Reference: '159050'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: 'E (Exact mapping: the two concepts are equivalent)'
      Reference: '300376'
      Source: OMIM
  Genes:
  - Gene:
      DisorderGeneAssociationType: Disease-causing germline mutation(s) in
      ExternalReferences: []
      Name: dystrophin
      Symbol: DMD
  Label: Becker muscular dystrophy
  ORPHAcode: '98895'
  ORPHApacketId: '98895'
  PURL: http://www.orpha.net/ORDO/Orphanet_98895
  Parents:
  - Parent:
    - Label: Duchenne and Becker muscular dystrophy
      ORPHAcode: '262'
  - Parent:
    - Label: Qualitative or quantitative defects of dystrophin
      ORPHAcode: '207085'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002355
      HPOTerm: Difficulty walking
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002913
      HPOTerm: Myoglobinuria
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0003236
      HPOTerm: Elevated circulating creatine kinase concentration
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0003326
      HPOTerm: Myalgia
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0003546
      HPOTerm: Exercise intolerance
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0003551
      HPOTerm: Difficulty climbing stairs
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0012086
      HPOTerm: Abnormal urinary color
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001324
      HPOTerm: Muscle weakness
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002527
      HPOTerm: Falls
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002814
      HPOTerm: Abnormality of the lower limb
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002910
      HPOTerm: Elevated hepatic transaminase
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0003394
      HPOTerm: Muscle spasm
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0012378
      HPOTerm: Fatigue
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001763
      HPOTerm: Pes planus
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0003202
      HPOTerm: Skeletal muscle atrophy
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0030051
      HPOTerm: Tip-toe gait
  Prevalences:
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: European Medicines Agency 2018[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 1673177[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19767415[PMID]_24780148[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 12495984[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: emedicine[OTHER]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: '[EXPERT]'
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 24780148[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Italy
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 10466417[PMID]_24780148[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Egypt
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 16210862[PMID]_24780148[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Japan
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 1745328[PMID]_24780148[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: South Africa
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 7825085[PMID]_24780148[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Ireland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 8845721[PMID]_24780148[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Puerto rico
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: DOI:10.3233/JND-160147[OTHER]
      ValMoy: no data
  Synonyms:
  - Synonym: BMD
  - Synonym: Becker dystrophinopathy
  TextSection:
    Contents: A rare genetic muscular dystrophy characterized by progressive muscle
      wasting and weakness due to degeneration of skeletal smooth and cardiac muscle.
    TextSectionType: Definition
  TypeOfInheritances:
    TypeOfInheritance:
    - value: X-linked recessive
  copyright: Orphanet (c) 2024
  creationDate: '2024-12-03 10:13:55'
  version: 1.3.29 / 4.1.7 [2023-08-02] (orientdb version)
